scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.3109/08820538.2011.588652 |
P698 | PubMed publication ID | 21958169 |
P2093 | author name string | Reza Dana | |
John L Clements | |||
P2860 | cites work | Vascular endothelial growth factor in eye disease | Q36929380 |
Inflammatory responses of corneal epithelial cells to Pseudomonas aeruginosa infection | Q37152332 | ||
Regulation of blood vessel versus lymphatic vessel growth in the cornea | Q37242034 | ||
Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. | Q37244781 | ||
Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest | Q37407741 | ||
Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands | Q37413669 | ||
Limbal stem cell deficiency and corneal neovascularization | Q37479357 | ||
Novel aspects of corneal angiogenic and lymphangiogenic privilege. | Q37681157 | ||
VLA proteins in the integrin family: structures, functions, and their role on leukocytes | Q37925528 | ||
Corneal epithelial MT1-MMP inhibits vascular endothelial cell proliferation and migration | Q39274186 | ||
Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target | Q39895356 | ||
Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment | Q40512782 | ||
The family of matrix metalloproteinases | Q40642303 | ||
Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity | Q40703354 | ||
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment | Q40725945 | ||
Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans | Q40831320 | ||
Very late antigen 1 blockade markedly promotes survival of corneal allografts | Q42062717 | ||
Cytokine expression in the alkali-burned cornea | Q42441159 | ||
Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors | Q42854407 | ||
Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops | Q43030654 | ||
Pigment epithelium-derived factor inhibits advanced glycation end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells | Q43264202 | ||
Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear | Q43873087 | ||
Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein | Q44485835 | ||
Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis. | Q45930394 | ||
Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis | Q46220745 | ||
Lactate elicits vascular endothelial growth factor from macrophages: a possible alternative to hypoxia | Q46432265 | ||
Bilateral corneal neovascularization and opacification associated with unmonitored contact lens wear | Q46486061 | ||
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity | Q47244359 | ||
Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway | Q47411466 | ||
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. | Q47697374 | ||
Topical modulation of interleukin-1 activity in corneal neovascularization | Q47794168 | ||
Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain | Q48632706 | ||
Oxidative stress due to hypoxia/reoxygenation induces angiogenic factor VEGF in adult rat myocardium: possible role of NFkappaB. | Q51368608 | ||
Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. | Q54654540 | ||
Inhibition of Hemangiogenesis and LymphangiogenesisafterNormal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival | Q57706454 | ||
Angiostatin binds ATP synthase on the surface of human endothelial cells | Q22009028 | ||
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 | ||
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 | ||
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis | Q28139159 | ||
A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability | Q28215378 | ||
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation | Q28285842 | ||
The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis | Q28344804 | ||
Corneal avascularity is due to soluble VEGF receptor-1 | Q28755125 | ||
Molecular regulation of vessel maturation | Q29614540 | ||
Angiogenesis in health and disease | Q29614541 | ||
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma | Q29615947 | ||
Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization | Q30650946 | ||
Hypoxia, overnight wear, and tear stagnation effects on the corneal epithelium: data and proposed model | Q31135017 | ||
Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival | Q33845555 | ||
Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis | Q33846832 | ||
Diminished corneal angiogenesis in gelatinase A-deficient mice | Q34102769 | ||
The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies | Q34107537 | ||
Herpes simplex virus keratitis: histopathologic neovascularization and corneal allograft failure | Q34113969 | ||
Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. | Q34130059 | ||
Neutrophil apoptosis: selective regulation by different ligands of integrin alphaMbeta2. | Q34296680 | ||
The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. | Q34317970 | ||
Matrix metalloproteinases and angiogenesis | Q34617852 | ||
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus | Q34785842 | ||
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision | Q34984061 | ||
Vascular endothelial growth factors and angiogenesis in eye disease | Q35070749 | ||
Evolution of the Fgf and Fgfr gene families | Q35913683 | ||
Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis | Q35963152 | ||
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis | Q36111400 | ||
VEGF as a key mediator of angiogenesis in cancer | Q36319024 | ||
Pericellular proteases in angiogenesis and vasculogenesis | Q36392557 | ||
Vascular endothelial growth factor C induces angiogenesis in vivo. | Q36734917 | ||
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies | Q36879368 | ||
P433 | issue | 4-5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
corneal neovascularization | Q1266519 | ||
neovascularization | Q1281049 | ||
P304 | page(s) | 235-245 | |
P577 | publication date | 2011-07-01 | |
P1433 | published in | Seminars in Ophthalmology | Q7449468 |
P1476 | title | Inflammatory corneal neovascularization: etiopathogenesis | |
P478 | volume | 26 |